Litigation Details for MYLAN PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS INDUSTRIES LTD. (D.N.J. 2021)
✉ Email this page to a colleague
MYLAN PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS INDUSTRIES LTD. (D.N.J. 2021)
| Docket | ⤷ Try a Trial | Date Filed | 2021-06-29 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:2 Antitrust Litigation | Assigned To | Julien Xavier Neals |
| Jury Demand | Plaintiff | Referred To | Jessica S. Allen |
| Patents | 10,039,745; 10,154,987; 9,669,008; 9,808,442 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MYLAN PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS INDUSTRIES LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for MYLAN PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS INDUSTRIES LTD. (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-01-05 | 135 | Letter | summarized in the ent), 10,039,745 (the ’745 patent), 10,772,868 table below: Case…litigation. 9,669,008, 9,808,442, 10,039,745, 10,- 154,987, 10,772,868, 10,786,482…,008 (the ’008 patent), 11,040,023 patent). (the ’023 patent), 11,141,405 (the…Hatch-Waxman lawsuits, two additional patent suits against Mylan, patent suits against Mylan’s foreign suppliers… (iv) water; tions differ from patent to patent, but the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
